M. Abbas, S. H. Ali Sami, M. Gajdács, and M. J. Tariq, “Recent FDA-approved kinase inhibitors for cancer therapy in 2025: A comprehensive review and perspectives”, EXCLI J., vol. 24, pp. 1609–1633, Nov. 2025.